The impact of treatment programmes on the epidemiology of tuberculosis.
D002681:China; D002908:Chronic Disease; D003906:Developing Countries; D006801:Humans; D007194:India; D007538:Isoniazid / Q000627:therapeutic use; D009426:Netherlands; D010349:Patient Compliance; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000453:epidemiology / Q000635:transmission
D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin